We deliver fully audit-centric, GMP-harmonized design and build solutions for modern biopharmaceutical manufacturing facilities, tailored for clinical trial production and commercial-scale biologic operations. Covering greenfield new-build projects and brownfield retrofit & compliance upgrading, our turnkey service integrates regulatory-aligned master planning, classified cleanroom engineering, sanitary utility deployment, process equipment layout and full lifecycle validation enablement. Differentiated from conventional construction models, our entire project execution is driven by inspection readiness, eliminating design gaps, construction non-conformities and validation loopholes. The final facility is built to sustain continuous audit resilience for monoclonal antibodies, recombinant proteins, mRNA vaccines, viral vectors and sterile biologic product lines.
Our audit-ready plant delivery adheres to the core principle ofcompliance embedded design, traceable construction execution, risk-eliminated process layout, and permanently inspectable infrastructure. Every zoning strategy, airflow configuration, personnel and material flow route, sanitary piping detail and utility control logic is engineered to eliminate common regulatory observation points. We adopt zero-dead-volume sanitary construction, hierarchical contamination control cascades and fully segregated multi-product workflows to ensure inherent process safety and batch consistency. Modular, standardized architecture guarantees long-term compliance adaptability amid evolving global GMP requirements.
All design criteria, construction specifications and operational configurations fully comply with FDA 21 CFR Part 210/211, EMA Annex 1, ICH Q8/Q9/Q10, PIC/S and ISPE baseline standards. We embed full data integrity mechanisms compliant with 21 CFR Part 11, ensuring immutable traceability for environmental monitoring, equipment operation, utility performance and full batch records. Every facility is pre-validated against bioburden control, cross-contamination prevention, aseptic stability and process reproducibility benchmarks, maintaining continuous inspection readiness for domestic and international regulatory audits and product licensing reviews.
We provide end-to-end compliant design and build services covering regulatory feasibility assessment, risk-based conceptual design, detailed engineering, quality-controlled construction, system commissioning and consolidated qualification dossier handover. Our audit-oriented execution model minimizes post-construction compliance remediation, shortens plant certification cycles and reduces long-term operational compliance risks. Clients obtain inherently compliant, inspection-stable and future-proof biomanufacturing facilities to accelerate product registration, ensure consistent production quality and sustain competitive advantages in the global biopharmaceutical market.
